These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9736496)
41. Relationship between cathepsin B, cathepsin D expression and biological behaviour in mucinous colorectal carcinoma. Wang Y; Lin X Chin Med Sci J; 2004 Mar; 19(1):12. PubMed ID: 15104218 [No Abstract] [Full Text] [Related]
42. A biodegradable multiblock co-polymer derived from an alpha, omega-bis(methylamino)peptide and an alpha, omega-bis(oxiranylmethyl)poly(ethylene glycol). Matthews1 SE; Pouton CW; Threadgill MD J Control Release; 2000 Jul; 67(2-3):129-39. PubMed ID: 10825548 [TBL] [Abstract][Full Text] [Related]
43. FRET-Based Cathepsin Probes for Simultaneous Detection of Cathepsin B and D Activities. Zhang Z; Nakata E; Shibano Y; Morii T Chembiochem; 2022 Oct; 23(19):e202200319. PubMed ID: 35929606 [TBL] [Abstract][Full Text] [Related]
44. Eliminating caspase-7 and cathepsin B cross-reactivity on fluorogenic caspase-3 substrates. Mackay M; Pérez-López AM; Bradley M; Lilienkampf A Mol Biosyst; 2016 Mar; 12(3):693-6. PubMed ID: 26726961 [TBL] [Abstract][Full Text] [Related]
45. Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers. Jin C; Ei-Sagheer AH; Li S; Vallis KA; Tan W; Brown T Angew Chem Int Ed Engl; 2022 Mar; 61(13):e202114016. PubMed ID: 34953094 [TBL] [Abstract][Full Text] [Related]
49. Strategies for rapid deconvolution of combinational libraries: comparative evaluation using a model system. Konings DA; Wyatt JR; Ecker DJ; Freier SM J Med Chem; 1997 Dec; 40(26):4386-95. PubMed ID: 9435908 [TBL] [Abstract][Full Text] [Related]
50. Cathepsin B and D activity in human skeletal muscle in disease states. Guarnieri G; Toigo G; Situlin R; Del Bianco MA; Crapesi L Adv Exp Med Biol; 1988; 240():243-56. PubMed ID: 3149867 [No Abstract] [Full Text] [Related]
51. Nanomechanical in situ monitoring of proteolysis of peptide by Cathepsin B. Kwon T; Park J; Yang J; Yoon DS; Na S; Kim CW; Suh JS; Huh YM; Haam S; Eom K PLoS One; 2009 Jul; 4(7):e6248. PubMed ID: 19606222 [TBL] [Abstract][Full Text] [Related]
52. Delivery of substances and their target-specific topical activation. Pipkorn R; Waldeck W; Spring H; Jenne JW; Braun K Biochim Biophys Acta; 2006 May; 1758(5):606-10. PubMed ID: 16730647 [TBL] [Abstract][Full Text] [Related]
54. Introduction to combinatorial solid-phase assays for enzyme activity and inhibition. Meldal M Methods Mol Biol; 1998; 87():51-7. PubMed ID: 9523258 [No Abstract] [Full Text] [Related]
55. Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds. Lawatscheck C; Pickhardt M; Wieczorek S; Grafmüller A; Mandelkow E; Börner HG Angew Chem Int Ed Engl; 2016 Jul; 55(30):8752-6. PubMed ID: 27282127 [TBL] [Abstract][Full Text] [Related]
57. Secondary Amino Alcohols: Traceless Cleavable Linkers for Use in Affinity Capture and Release. Pomplun S; Shugrue CR; Schmitt AM; Schissel CK; Farquhar CE; Pentelute BL Angew Chem Int Ed Engl; 2020 Jul; 59(28):11566-11572. PubMed ID: 32227406 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of a one-bead one-compound combinatorial peptide library. Lam KS; Lebl M Methods Mol Biol; 1998; 87():1-6. PubMed ID: 9523253 [No Abstract] [Full Text] [Related]
59. Oxidation-labile linkers for controlled drug delivery. Carneiro A; Santana L; Matos MJ Bioorg Med Chem Lett; 2023 May; 87():129264. PubMed ID: 37004925 [TBL] [Abstract][Full Text] [Related]
60. Emerging Applications of Fluorogenic and Non-fluorogenic Bifunctional Linkers. Liu G; Hu J; Liu S Chemistry; 2018 Nov; 24(62):16484-16505. PubMed ID: 29893499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]